• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

与心脏再同步治疗后二尖瓣反流改善相关的机制特征及其与长期患者预后的关系。

Mechanistic features associated with improvement in mitral regurgitation after cardiac resynchronization therapy and their relation to long-term patient outcome.

机构信息

Heart and Vascular Institute, University of Pittsburgh, Pittsburgh, PA 15213-2582, USA.

出版信息

Circ Heart Fail. 2013 Jul;6(4):685-93. doi: 10.1161/CIRCHEARTFAILURE.112.000112. Epub 2013 Jun 3.

DOI:10.1161/CIRCHEARTFAILURE.112.000112
PMID:23733917
Abstract

BACKGROUND

Mechanisms of mitral regurgitation (MR) reduction with cardiac resynchronization therapy (CRT) are complex, and their association with long-term outcome is unclear. We sought to elucidate mechanistic features of reduction in MR with CRT, which impact long-term patient survival.

METHODS AND RESULTS

A prospective longitudinal study of 277 patients with heart failure with QRS width ≥ 120 ms and ejection fraction ≤ 35% for CRT was performed. Quantitative echocardiography, including dyssynchrony analysis, was performed at baseline. MR was quantified by color Doppler before and 6 months after CRT. Predefined end points of death, transplant, or left ventricular assist device were tracked during 4 years. There were 114 (48%) patients with CRT with significant MR (≥ moderate) at baseline; of whom 48 (42%) patients had MR improvement, and 24 (19%) patients had MR worsening after CRT. The 66 events (47 deaths, 10 transplantations, and 9 left ventricular assist devices) were strongly associated with significant MR after CRT (hazard ratio, 3.58; 95% confidence interval, 2.18-5.87; P<0.0001). Three echocardiographic features were independently associated with amelioration of significant MR after CRT by multivariable analysis: anteroseptal to posterior wall radial strain dyssynchrony >200 ms, lack of severe left ventricular dilatation (end-systolic dimension index <29 mm/m(2)), and lack of echocardiographic scar at papillary muscle insertion sites (all P<0.05) and, when combined, were additively associated with long-term survival (P=0.0001).

CONCLUSIONS

Significant MR after CRT was strongly associated with less favorable long-term survival. Echocardiographic mechanistic features were identified that were associated with improvement in MR after CRT and favorable long-term survival.

摘要

背景

心脏再同步治疗(CRT)减少二尖瓣反流(MR)的机制很复杂,其与长期预后的关系尚不清楚。我们旨在阐明 CRT 减少 MR 的机制特征,这些特征会影响患者的长期生存。

方法和结果

对 277 例 QRS 宽度≥120ms 且射血分数≤35%的心力衰竭患者进行了前瞻性纵向研究,这些患者适合 CRT。在基线时进行了定量超声心动图检查,包括对不同步性进行分析。在 CRT 前和 CRT 后 6 个月使用彩色多普勒评估 MR。在 4 年内跟踪死亡、移植或左心室辅助装置的预定终点。基线时有 114 例(48%)患者的 CRT 伴中重度以上的 MR;其中 48 例(42%)患者的 MR 改善,24 例(19%)患者的 MR 恶化。66 例事件(47 例死亡、10 例移植、9 例左心室辅助装置)与 CRT 后严重 MR 密切相关(危险比,3.58;95%置信区间,2.18-5.87;P<0.0001)。多变量分析显示,3 种超声心动图特征与 CRT 后 MR 改善独立相关:前间隔至后间隔径向应变不同步性>200ms、无严重左心室扩张(收缩末期内径指数<29mm/m2)和心肌乳头肌插入部位无超声心动图瘢痕(均 P<0.05),当这些因素结合时,与长期生存呈累加相关(P=0.0001)。

结论

CRT 后严重的 MR 与预后较差的长期生存密切相关。确定了与 CRT 后 MR 改善和良好的长期生存相关的超声心动图机制特征。

相似文献

1
Mechanistic features associated with improvement in mitral regurgitation after cardiac resynchronization therapy and their relation to long-term patient outcome.与心脏再同步治疗后二尖瓣反流改善相关的机制特征及其与长期患者预后的关系。
Circ Heart Fail. 2013 Jul;6(4):685-93. doi: 10.1161/CIRCHEARTFAILURE.112.000112. Epub 2013 Jun 3.
2
Acute effects of initiation and withdrawal of cardiac resynchronization therapy on papillary muscle dyssynchrony and mitral regurgitation.心脏再同步治疗的启动和撤机对乳头肌不同步和二尖瓣反流的急性影响。
J Am Coll Cardiol. 2007 Nov 20;50(21):2071-7. doi: 10.1016/j.jacc.2007.08.019. Epub 2007 Nov 7.
3
A mechanism for immediate reduction in mitral regurgitation after cardiac resynchronization therapy: insights from mechanical activation strain mapping.心脏再同步治疗后二尖瓣反流立即减轻的机制:来自机械激活应变映射的见解
J Am Coll Cardiol. 2004 Oct 19;44(8):1619-25. doi: 10.1016/j.jacc.2004.07.036.
4
Impact of cardiac resynchronization therapy on the severity of mitral regurgitation.心脏再同步治疗对二尖瓣反流严重程度的影响。
Europace. 2011 Jun;13(6):829-38. doi: 10.1093/europace/eur047. Epub 2011 Apr 12.
5
Relationship of echocardiographic dyssynchrony to long-term survival after cardiac resynchronization therapy.超声心动图不同步与心脏再同步治疗后长期生存的关系。
Circulation. 2010 Nov 9;122(19):1910-8. doi: 10.1161/CIRCULATIONAHA.110.954768. Epub 2010 Oct 25.
6
Time course of secondary mitral regurgitation in patients with heart failure receiving cardiac resynchronization therapy: Impact on long-term outcome beyond left ventricular reverse remodelling.心力衰竭患者心脏再同步治疗后继发性二尖瓣反流的时间进程:对左心室逆重构后长期结局的影响。
Arch Cardiovasc Dis. 2018 May;111(5):320-331. doi: 10.1016/j.acvd.2017.05.009. Epub 2017 Nov 6.
7
Impact of mitral regurgitation on reverse remodeling and outcome in patients undergoing cardiac resynchronization therapy.二尖瓣反流对心脏再同步治疗患者逆重构和结局的影响。
Circ Cardiovasc Imaging. 2012 Jan;5(1):21-6. doi: 10.1161/CIRCIMAGING.111.966580. Epub 2011 Nov 2.
8
Longer Left Ventricular Electric Delay Reduces Mitral Regurgitation After Cardiac Resynchronization Therapy: Mechanistic Insights From the SMART-AV Study (SmartDelay Determined AV Optimization: A Comparison to Other AV Delay Methods Used in Cardiac Resynchronization Therapy).更长的左心室电延迟可减少心脏再同步治疗后的二尖瓣反流:来自SMART-AV研究(智能延迟确定房室优化:与心脏再同步治疗中使用的其他房室延迟方法的比较)的机制性见解
Circ Arrhythm Electrophysiol. 2016 Nov;9(11). doi: 10.1161/CIRCEP.116.004346.
9
Native Electrocardiographic QRS Duration after Cardiac Resynchronization Therapy: The Impact on Clinical Outcomes and Prognosis.心脏再同步治疗后心电图QRS波群固有时限:对临床结局和预后的影响
J Card Fail. 2016 Oct;22(10):772-80. doi: 10.1016/j.cardfail.2016.04.001. Epub 2016 Apr 4.
10
Cardiac resynchronization therapy as a therapeutic option in patients with moderate-severe functional mitral regurgitation and high operative risk.心脏再同步治疗作为中重度功能性二尖瓣反流且手术风险高的患者的一种治疗选择。
Circulation. 2011 Aug 23;124(8):912-9. doi: 10.1161/CIRCULATIONAHA.110.009803. Epub 2011 Aug 1.

引用本文的文献

1
Addressing Functional Mitral Regurgitation in Dilated Cardiomyopathy: A Focus on Myocardial Segment Resynchronization Through Cardiac Resynchronization Therapy.解决扩张型心肌病中的功能性二尖瓣反流:聚焦于通过心脏再同步治疗实现心肌节段再同步化
Cureus. 2024 Nov 24;16(11):e74374. doi: 10.7759/cureus.74374. eCollection 2024 Nov.
2
Evolution and prognosis of tricuspid and mitral regurgitation following cardiac implantable electronic devices: a systematic review and meta-analysis.心脏植入式电子设备后三尖瓣和二尖瓣反流的演变和预后:系统评价和荟萃分析。
Europace. 2024 Jul 2;26(7). doi: 10.1093/europace/euae143.
3
Persistence of significant secondary mitral regurgitation post-cardiac resynchronization therapy and survival: a systematic review and meta-analysis : Mitral regurgitation and mortality post-CRT.
心脏再同步化治疗后持续性中重度二尖瓣反流与生存:系统评价和荟萃分析:CRT 后二尖瓣反流与死亡率。
Heart Fail Rev. 2024 Jan;29(1):165-178. doi: 10.1007/s10741-023-10359-6. Epub 2023 Oct 19.
4
Perspectives on Secondary Mitral Regurgitation in Heart Failure.心力衰竭中继发性二尖瓣反流的观点
Curr Heart Fail Rep. 2023 Oct;20(5):417-428. doi: 10.1007/s11897-023-00627-9. Epub 2023 Sep 11.
5
Functional Mitral and Tricuspid Regurgitation across the Whole Spectrum of Left Ventricular Ejection Fraction: Recognizing the Elephant in the Room of Heart Failure.全谱左心室射血分数范围内的功能性二尖瓣和三尖瓣反流:识别心力衰竭房间里的大象。
J Clin Med. 2023 May 6;12(9):3316. doi: 10.3390/jcm12093316.
6
The Role of Cardiac Resynchronization Therapy for the Management of Functional Mitral Regurgitation.心脏再同步治疗在功能性二尖瓣反流管理中的作用。
Cells. 2022 Aug 4;11(15):2407. doi: 10.3390/cells11152407.
7
Impact of S-Wave Amplitude in Right Precordial Leads on Improvement in Mitral Regurgitation following Cardiac Resynchronization Therapy.右心前区导联S波振幅对心脏再同步治疗后二尖瓣反流改善情况的影响
J Cardiovasc Dev Dis. 2022 May 16;9(5):159. doi: 10.3390/jcdd9050159.
8
Predictors of persistence of functional mitral regurgitation after cardiac resynchronization therapy: Review of literature.心脏再同步治疗后功能性二尖瓣反流持续存在的预测因素:文献综述
World J Cardiol. 2022 Mar 26;14(3):170-176. doi: 10.4330/wjc.v14.i3.170.
9
Tricuspid regurgitation after cardiac resynchronization therapy: evolution and prognostic significance.三尖瓣反流心脏再同步治疗后:演变和预后意义。
Europace. 2022 Sep 1;24(8):1291-1299. doi: 10.1093/europace/euac034.
10
The role of surgery for secondary mitral regurgitation and heart failure in the era of transcatheter mitral valve therapies.经导管二尖瓣治疗时代的手术在二尖瓣反流和心力衰竭二级预防中的作用。
Rev Cardiovasc Med. 2022 Mar 4;23(3):87. doi: 10.31083/j.rcm2303087.